NCT04360174View on ClinicalTrials.gov

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

May 24, 2021

Study Completion Date

May 24, 2021

Conditions
Ocular HypertensionOpen Angle Glaucoma
Interventions
DRUG

OTX-TIC

OTX-TIC implant is injection in the anterior chamber of the eye

Trial Locations (5)

30076

Ocular Therapeutix, Inc, Roswell

53405

Ocular Therapeutix, Inc., Racine

78731

Ocular Therapeutix, Inc., Austin

90505

Ocular Therapeutix, Inc., Torrance

94954

Ocular Therapeutix, Inc., Petaluma

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY